Description

Moxogamma (moxonidinum) Coated Tablets 0.2 mg. №30

Ingredients:

Each coated tablet contains 0.2 mg of moxonidinum as the active ingredient.

Dosage:

The recommended dosage is one tablet daily, preferably in the morning. It is important to follow the instructions of your healthcare provider.

Indications:

Moxogamma tablets are indicated for the treatment of essential hypertension. They help lower blood pressure by relaxing and dilating blood vessels.

Contraindications:

Do not use Moxogamma tablets if you are allergic to moxonidinum or if you have severe bradycardia. Consult your doctor before starting this medication.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Take it at the same time each day for best results.

Scientific Evidence:

Moxonidine, the active ingredient in Moxogamma tablets, has been extensively studied for its efficacy in treating hypertension. Research published in the Journal of Hypertension has shown that moxonidine effectively reduces blood pressure levels in patients with essential hypertension. Additionally, a meta-analysis published in the European Heart Journal demonstrated that moxonidine is well-tolerated and provides significant antihypertensive effects.

Additional Information:

It is important to monitor your blood pressure regularly while taking Moxogamma tablets. Inform your healthcare provider about any other medications you are taking to avoid potential drug interactions. If you experience any unusual symptoms or side effects, seek medical attention promptly.

Pharmacological Effects: Moxonidine acts centrally to reduce sympathetic nervous system activity, leading to decreased peripheral resistance and lower blood pressure. This mechanism of action differentiates moxonidine from other antihypertensive agents, making it a valuable option for patients with hypertension.

Clinical Trials: Clinical trials have shown that Moxogamma tablets are effective in lowering blood pressure and maintaining long-term control of hypertension. A study published in the American Journal of Hypertension demonstrated the superior efficacy of moxonidine compared to placebo in reducing both systolic and diastolic blood pressure levels.